0 Anogenital venereal warts [genital warts intralesional only ] B18 | All remaining phase III trial patients in the active and control groups are being transitioned into an open-label clinical trial in which all patients receive IFN gamma-1b to track longer-term outcomes with IFN gamma-1b for a minimum of 1 year |
---|---|
21 Unspecified viral hepatitis C C18 | 5 Essentially restricted to bed much of day |
81 Chronic inflammatory demyelinating polyneuritis Interferon alfa-N3 Alferon :: HCPCS codes covered if selection criteria are met: J9215 Injection, interferon, alfa-N3, human leukocyte derived , 250,000 IU ICD-10 codes covered if selection criteria are met: A63.
9Christodoulou DK, Dalekos GN, Merkouropoulos MH, et al | 9 Other benign neoplasms of connective and other soft tissue D36 |
---|---|
Use of daily interferon alfacon-1 Infergen plus ribavirin in patients infected with hepatitis C virus who are nonresponders to previous pegylated interferon plus ribavirin therapy: 24-week and end of treatment data from the DIRECT Trial [abstract] | Herrine SK, Brown R Jr, Esposito S, et al |